Download PDF
Thromb Haemost 1999; 82(05): 1380-1381
DOI: 10.1055/s-0037-1614778
Commentary
Schattauer GmbH

Thrombotic Thrombocytopenic Purpura: A Simpler Diagnosis at last?

P. M. Mannucci
1   From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Department of Internal Medicine, IRCCS Maggiore Hospital and University of Milan, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

Keywords

Thrombotic thrombocytopenic purpura - hemolytic uremic syndrome - von Willebrand factor
 

  • References

  • 1 Moschcovitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924; 24: 21-4.
    PubMedGoogle Scholar
  • 2 Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-5.
    CrossrefPubMedGoogle Scholar
  • 3 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (VWF) multimers and unusually large VWF forms derived from endothelial cells in shear-stress induced platelet aggregation. J Clin Invest 1986; 78: 1456-61.
    CrossrefPubMedGoogle Scholar
  • 4 Mannucci PM, Lombardi R, Lattuada A, Ruggenenti P, Viganò GL, Barbui T, Remuzzi G. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood 1989; 74: 978-3.
    PubMedGoogle Scholar
  • 5 Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4235-44.
    PubMedGoogle Scholar
  • 6 Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
    PubMedGoogle Scholar
  • 7 Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89: 3097-3103.
    PubMedGoogle Scholar
  • 8 Furlan M, Robles R, Solenthaler M, Lämmle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 1998; 91: 2839-46.
    PubMedGoogle Scholar
  • 9 Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. Von Willebrand factor-cleaving protease in thormbotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
    CrossrefPubMedGoogle Scholar
  • 10 Tsai HM, Lian ECY. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
    CrossrefPubMedGoogle Scholar
  • 11 Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M. Assay of von Willebrand factor (VWF)-cleaving protease based on decreased collagen binding affinity of degraded VWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999; 82: 1386-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Obert B, Tout H, Veyradier A, Fressinaud E, Meyer D, Girma JP. Rapid and sensitive estimation of the von Willebrand Factor-cleaving protease in plasma using monoclonal antibodies to VWF. Thromb Haemost 1999; 82: 1382-5.
    Article in Thieme ConnectPubMedGoogle Scholar